This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: The General Hospital Corporation, The Brigham and Women's Hospital, Inc.. Active years: 2013-2025.
Company Filing History:
5 out of 3,071 
1 out of 1,425 
Years Active: 2013-2025
Title: Innovations and Contributions of Inventor Keith W. Miller
Introduction
Keith W. Miller is a notable inventor based in Lincoln, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic approaches. With a total of 5 patents, his work has the potential to impact cancer treatment and autoimmune diseases.
Latest Patents
Miller's latest patents include groundbreaking inventions such as tethered interleukin-2 to its receptor IL-2RBETA, which enhances natural killer and regulatory T cell activity. This includes fusion proteins comprising IL2 and IL2Rβ, IL2, IL2Rβ, and IL21R, and methods of use for treating cancer. Additionally, he has developed etomidate analogues that do not inhibit adrenocortical steroid synthesis, which are directed towards providing anesthesia in mammals through pharmaceutical compositions.
Career Highlights
Throughout his career, Miller has worked with prestigious institutions such as The General Hospital Corporation and Brigham and Women's Hospital, Inc. His research has focused on creating innovative solutions that address critical health challenges.
Collaborations
Miller has collaborated with esteemed colleagues, including Stuart A. Forman and Joseph F. Cotten, to advance his research and inventions.
Conclusion
Keith W. Miller's contributions to the field of biomedical innovation are noteworthy, and his patents reflect a commitment to improving health outcomes through scientific advancement. His work continues to inspire future research and development in the medical field.